SCHEMBL413451

SCHEMBL413451

O=C(c1ccc2[nH]ccc2c1)C1(c2ccccc2)CCNCC1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.67
SLC6A4 P31645 12/20 0.67
SLC6A3 Q01959 12/20 0.67
CTNNB1 P35222 1/20 0.50
WNT3A P56704 1/20 0.50
CYP2D6 P10635 5/20 0.48
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
ROCK2 O75116 2/20 0.46
KCNH2 Q12809 1/20 0.46
MAPK14 Q16539 1/20 0.44
HDAC1 Q13547 1/20 0.44
OPRM1 P35372 1/20 0.43
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL413442 0.93 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
Tert-Butyl Formate SCHEMBL27762080 0.89 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL12350552 0.85 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL414728 0.81 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL7312326 0.78 OPRM1 (0.56) HDAC1OPRM1
SCHEMBL27762079 0.78 CNR1 (0.46) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL443982 0.78 TSHR (0.49) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL413862 0.77 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL413745 0.76 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A
SCHEMBL414612 0.76 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CTNNB1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101563319-B Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives HOFFMANN LA ROCHE 2012-09-05 CN claimed
EP-2102157-B1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-06-22 EP claimed
EP-2684871-B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives HOFFMANN LA ROCHE (CH) 2016-05-04 EP disclosed
EP-2684871-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives F. Hoffmann-La Roche AG (CH) 2014-01-15 EP disclosed
US-8513425-B2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2013-08-20 US disclosed
US-8513425-B2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2013-08-20 US disclosed
CN-101563319-B Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives HOFFMANN LA ROCHE 2012-09-05 CN disclosed
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF IYER PRAVIN (US) 2012-03-15 US disclosed
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF IYER PRAVIN (US) 2012-03-15 US disclosed
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF IYER PRAVIN (US) 2012-03-15 US disclosed
US-8084623-B2 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents ROCHE PALO ALTO LLC (US) 2011-12-27 US disclosed
CN-102066320-A Aryl ketone as MRI HOFFMANN LA ROCHE 2011-05-18 CN disclosed
EP-2297096-A2 ARYL KETONE AS MRI F. Hoffmann-La Roche AG (CH) 2011-03-23 EP disclosed
US-20090318493-A1 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2009-12-24 US disclosed
WO-2009153178-A2 ARYL KETONE AS MRI F. HOFFMANN-LA ROCHE AG (CH) 2009-12-23 WO disclosed
CN-101563319-A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives HOFFMANN LA ROCHE (CH) 2009-10-21 CN disclosed
WO-2008074703-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-26 WO disclosed
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF CNKSR1, RB1, AR SLC6A2 4870/4885SLC6A4 4855/4885SLC6A3 4745/4885
US-20080146607-A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof CNKSR1, RB1, AR SLC6A2 4870/4885SLC6A4 4855/4885SLC6A3 4745/4885
US-20090318493-A1 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof TPH2, TPH1, ADRA2C SLC6A2 71/4885SLC6A4 57/4885SLC6A3 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.